US biotech developing oral KCC2-targeting neuromedicines for epilepsy and pain.
Founders
Joanna Stanicka(Ireland · ♀)— A Harvard-trained UCC scientist and drug hunter who co-invented Axonis' KCC2-targeting IP and co-founded the company in 2020, leading it as CEO to develop neuromedicines for epilepsy and pain.
Shane Hegarty(Ireland · ♂)— A UCC and Harvard neuroscientist whose award-winning neuro-regeneration research at Boston Children's Hospital became the IP behind Axonis, which he co-founded as Chief Scientific Officer.
Team & hubs
Members see the full profile
Create a free EquityFlow account to see Axonis Therapeutics's 2 funding rounds, 9 investors, 12 similar companies.